| Literature DB >> 19265012 |
Douglas D Richman1, David M Margolis, Martin Delaney, Warner C Greene, Daria Hazuda, Roger J Pomerantz.
Abstract
Although combination therapy for HIV infection represents a triumph for modern medicine, chronic suppressive therapy is required to contain persistent infection in reservoirs such as latently infected CD4+ lymphocytes and cells of the macrophage-monocyte lineage. Despite its success, chronic suppressive therapy is limited by its cost, the requirement of lifelong adherence, and the unknown effects of long-term treatment. This review discusses our current understanding of suppressive antiretroviral therapy, the latent viral reservoir, and the needs for and challenges of attacking this reservoir to achieve a cure.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19265012 DOI: 10.1126/science.1165706
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728